xml_file stringlengths 5 11 | reference_id stringlengths 1 7 | date_last_updated stringclasses 487
values | pubmed_id stringlengths 5 8 ⌀ | article_year int64 1.95k 2.03k ⌀ | article_title stringlengths 23 347 ⌀ | journal_title stringlengths 3 197 ⌀ | authors stringlengths 5 2.35k ⌀ | epitope_id stringlengths 1 7 ⌀ | epitope_name stringlengths 1 85 ⌀ | epitope_structure_type stringclasses 8
values | epitope_chemical_type stringclasses 18
values | linear_sequence stringlengths 1 829 ⌀ | linear_sequence_length int64 1 829 ⌀ | discontinuous_residues stringlengths 2 419 ⌀ | starting_position int64 0 34.8k ⌀ | ending_position int64 3 34.8k ⌀ | source_organism_id stringlengths 1 8 ⌀ | source_molecule_genbank_id stringlengths 4 14 ⌀ | reference_region stringlengths 2 409 ⌀ | epitope_structure_defines stringclasses 4
values | epitope_evidence_code stringclasses 6
values | assay_category stringclasses 4
values | assay_id stringlengths 2 8 | assay_type_id stringclasses 412
values | assay_location_of_data stringlengths 4 126 ⌀ | qualitative_measurement stringclasses 5
values | is_positive bool 2
classes | quantitative_measurement stringlengths 3 25 ⌀ | host_organism_id stringclasses 729
values | host_sex stringclasses 2
values | host_age stringlengths 1 39 ⌀ | disease_state stringclasses 666
values | mhc_allele_id stringclasses 868
values | mhc_allele_types_present stringlengths 1 150 ⌀ | cell_type stringclasses 41
values | cell_tissue_type stringclasses 49
values | cell_culture_conditions stringclasses 9
values | antigen_evidence_code stringclasses 6
values | immunogen_evidence_code stringclasses 6
values | assay_comments stringclasses 0
values | split_bucket int64 1 9 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
315262.xml | 315262 | 2025-11-06-08:00 | 9664088 | 1,998 | Cytotoxic T cell response against the chimeric ETV6-AML1 protein in childhood acute lymphoblastic leukemia. | The Journal of clinical investigation | P Yotnda; F Garcia; M Peuchmaur; B Grandchamp; M Duval; F Lemonnier; E Vilmer; P Langlade-Demoyen | 1311807 | ETV6 24-32 | FragmentOfANaturalSequenceMolecule | Peptide from protein | RIAECILGM | 9 | null | 24 | 32 | 9606 | 1421616448 | null | Exact Epitope | null | MhcBinding | 22389721 | 286 | Figure 1 | Positive-High | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
315262.xml | 315262 | 2025-11-06-08:00 | 9664088 | 1,998 | Cytotoxic T cell response against the chimeric ETV6-AML1 protein in childhood acute lymphoblastic leukemia. | The Journal of clinical investigation | P Yotnda; F Garcia; M Peuchmaur; B Grandchamp; M Duval; F Lemonnier; E Vilmer; P Langlade-Demoyen | 2189178 | ETV6 25-33 | FragmentOfANaturalSequenceMolecule | Peptide from protein | IAECILGMN | 9 | null | 25 | 33 | 9606 | 1421616448 | null | Exact Epitope | null | MhcBinding | 22389722 | 286 | Figure 1 | Negative | false | null | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
315262.xml | 315262 | 2025-11-06-08:00 | 9664088 | 1,998 | Cytotoxic T cell response against the chimeric ETV6-AML1 protein in childhood acute lymphoblastic leukemia. | The Journal of clinical investigation | P Yotnda; F Garcia; M Peuchmaur; B Grandchamp; M Duval; F Lemonnier; E Vilmer; P Langlade-Demoyen | 2189073 | ETV6 26-34 | FragmentOfANaturalSequenceMolecule | Peptide from protein | AECILGMNP | 9 | null | 26 | 34 | 9606 | 1421616448 | null | Exact Epitope | null | MhcBinding | 22389723 | 286 | Figure 1 | Negative | false | null | null | null | null | null | null | null | null | null | null | null | null | null | 9 |
315262.xml | 315262 | 2025-11-06-08:00 | 9664088 | 1,998 | Cytotoxic T cell response against the chimeric ETV6-AML1 protein in childhood acute lymphoblastic leukemia. | The Journal of clinical investigation | P Yotnda; F Garcia; M Peuchmaur; B Grandchamp; M Duval; F Lemonnier; E Vilmer; P Langlade-Demoyen | 2189106 | ETV6 27-35 | FragmentOfANaturalSequenceMolecule | Peptide from protein | ECILGMNPS | 9 | null | 27 | 35 | 9606 | 1421616448 | null | Exact Epitope | null | MhcBinding | 22389724 | 286 | Figure 1 | Negative | false | null | null | null | null | null | null | null | null | null | null | null | null | null | 8 |
315262.xml | 315262 | 2025-11-06-08:00 | 9664088 | 1,998 | Cytotoxic T cell response against the chimeric ETV6-AML1 protein in childhood acute lymphoblastic leukemia. | The Journal of clinical investigation | P Yotnda; F Garcia; M Peuchmaur; B Grandchamp; M Duval; F Lemonnier; E Vilmer; P Langlade-Demoyen | 16850 | HBV | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FLPSDYFPSV | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 22389725 | 286 | Figure 1 | Positive-High | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 9 |
315263.xml | 315263 | 2026-02-03-08:00 | 9670985 | 1,998 | Immunity to T cell receptor peptides in multiple sclerosis. III. Preferential immunogenicity of complementarity-determining region 2 peptides from disease-associated T cell receptor BV genes. | Journal of immunology (Baltimore, Md. : 1950) | D N Bourdette; Y K Chou; R H Whitham; J Buckner; H J Kwon; G T Nepom; A Buenafe; S A Cooper; M Allegretta; G A Hashim; H Offner; A A Vandenbark | 115833 | BV5S2 13-33 | FragmentOfANaturalSequenceMolecule | Peptide from protein | KTRGQQVTLRCSPKSGHDTVS | 21 | null | 32 | 52 | 9606 | AAB63910.1 | null | Epitope containing region/antigenic site | Representative selection | TCell | 1682157 | 69 | Figures 1, 2, and 3 | Negative | false | null | 9606 | null | 33-66 years | DOID:2377 | 304 | null | PBMC | blood | Direct Ex Vivo | Exact match to reference information | Exact match to reference information | null | 6 |
315263.xml | 315263 | 2026-02-03-08:00 | 9670985 | 1,998 | Immunity to T cell receptor peptides in multiple sclerosis. III. Preferential immunogenicity of complementarity-determining region 2 peptides from disease-associated T cell receptor BV genes. | Journal of immunology (Baltimore, Md. : 1950) | D N Bourdette; Y K Chou; R H Whitham; J Buckner; H J Kwon; G T Nepom; A Buenafe; S A Cooper; M Allegretta; G A Hashim; H Offner; A A Vandenbark | 115833 | BV5S2 13-33 | FragmentOfANaturalSequenceMolecule | Peptide from protein | KTRGQQVTLRCSPKSGHDTVS | 21 | null | 32 | 52 | 9606 | AAB63910.1 | null | Epitope containing region/antigenic site | Representative selection | MhcBinding | 1682186 | 273 | Table IV | Negative | false | 10.0 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
315263.xml | 315263 | 2026-02-03-08:00 | 9670985 | 1,998 | Immunity to T cell receptor peptides in multiple sclerosis. III. Preferential immunogenicity of complementarity-determining region 2 peptides from disease-associated T cell receptor BV genes. | Journal of immunology (Baltimore, Md. : 1950) | D N Bourdette; Y K Chou; R H Whitham; J Buckner; H J Kwon; G T Nepom; A Buenafe; S A Cooper; M Allegretta; G A Hashim; H Offner; A A Vandenbark | 115833 | BV5S2 13-33 | FragmentOfANaturalSequenceMolecule | Peptide from protein | KTRGQQVTLRCSPKSGHDTVS | 21 | null | 32 | 52 | 9606 | AAB63910.1 | null | Epitope containing region/antigenic site | Representative selection | MhcBinding | 1682176 | 273 | Table IV | Negative | false | 10.0 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
315263.xml | 315263 | 2026-02-03-08:00 | 9670985 | 1,998 | Immunity to T cell receptor peptides in multiple sclerosis. III. Preferential immunogenicity of complementarity-determining region 2 peptides from disease-associated T cell receptor BV genes. | Journal of immunology (Baltimore, Md. : 1950) | D N Bourdette; Y K Chou; R H Whitham; J Buckner; H J Kwon; G T Nepom; A Buenafe; S A Cooper; M Allegretta; G A Hashim; H Offner; A A Vandenbark | 115891 | BV5S2 25-42 | FragmentOfANaturalSequenceMolecule | Peptide from protein | PKSGHDTVSWYQQALGQG | 18 | null | 44 | 61 | 9606 | AAB63910.1 | null | Epitope containing region/antigenic site | Representative selection | TCell | 1682158 | 69 | Figures 2, 3, and 4, Table III | Positive | true | null | 9606 | null | 33-66 years | DOID:2377 | 436 | null | PBMC | blood | Direct Ex Vivo | Exact match to reference information | Exact match to reference information | null | 5 |
315263.xml | 315263 | 2026-02-03-08:00 | 9670985 | 1,998 | Immunity to T cell receptor peptides in multiple sclerosis. III. Preferential immunogenicity of complementarity-determining region 2 peptides from disease-associated T cell receptor BV genes. | Journal of immunology (Baltimore, Md. : 1950) | D N Bourdette; Y K Chou; R H Whitham; J Buckner; H J Kwon; G T Nepom; A Buenafe; S A Cooper; M Allegretta; G A Hashim; H Offner; A A Vandenbark | 115891 | BV5S2 25-42 | FragmentOfANaturalSequenceMolecule | Peptide from protein | PKSGHDTVSWYQQALGQG | 18 | null | 44 | 61 | 9606 | AAB63910.1 | null | Epitope containing region/antigenic site | Representative selection | MhcBinding | 1682187 | 273 | Table IV | Negative | false | 10.0 | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
315263.xml | 315263 | 2026-02-03-08:00 | 9670985 | 1,998 | Immunity to T cell receptor peptides in multiple sclerosis. III. Preferential immunogenicity of complementarity-determining region 2 peptides from disease-associated T cell receptor BV genes. | Journal of immunology (Baltimore, Md. : 1950) | D N Bourdette; Y K Chou; R H Whitham; J Buckner; H J Kwon; G T Nepom; A Buenafe; S A Cooper; M Allegretta; G A Hashim; H Offner; A A Vandenbark | 115891 | BV5S2 25-42 | FragmentOfANaturalSequenceMolecule | Peptide from protein | PKSGHDTVSWYQQALGQG | 18 | null | 44 | 61 | 9606 | AAB63910.1 | null | Epitope containing region/antigenic site | Representative selection | MhcBinding | 1682177 | 273 | Table IV | Positive-Intermediate | true | 200.0 | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
315263.xml | 315263 | 2026-02-03-08:00 | 9670985 | 1,998 | Immunity to T cell receptor peptides in multiple sclerosis. III. Preferential immunogenicity of complementarity-determining region 2 peptides from disease-associated T cell receptor BV genes. | Journal of immunology (Baltimore, Md. : 1950) | D N Bourdette; Y K Chou; R H Whitham; J Buckner; H J Kwon; G T Nepom; A Buenafe; S A Cooper; M Allegretta; G A Hashim; H Offner; A A Vandenbark | 115989 | BV5S2 33-52 | FragmentOfANaturalSequenceMolecule | Peptide from protein | SWYQQALGQGPQFIFQYYEE | 20 | null | 52 | 71 | 9606 | AAB63910.1 | null | Epitope containing region/antigenic site | Representative selection | TCell | 1682159 | 69 | Figures 1, 2, 3, and 4, Table III | Positive | true | null | 9606 | null | 33-66 years | DOID:2377 | 304 | null | PBMC | blood | Direct Ex Vivo | Exact match to reference information | Exact match to reference information | null | 4 |
315263.xml | 315263 | 2026-02-03-08:00 | 9670985 | 1,998 | Immunity to T cell receptor peptides in multiple sclerosis. III. Preferential immunogenicity of complementarity-determining region 2 peptides from disease-associated T cell receptor BV genes. | Journal of immunology (Baltimore, Md. : 1950) | D N Bourdette; Y K Chou; R H Whitham; J Buckner; H J Kwon; G T Nepom; A Buenafe; S A Cooper; M Allegretta; G A Hashim; H Offner; A A Vandenbark | 115989 | BV5S2 33-52 | FragmentOfANaturalSequenceMolecule | Peptide from protein | SWYQQALGQGPQFIFQYYEE | 20 | null | 52 | 71 | 9606 | AAB63910.1 | null | Epitope containing region/antigenic site | Representative selection | MhcBinding | 1682178 | 273 | Table IV | Positive-Low | true | 10000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 4 |
315263.xml | 315263 | 2026-02-03-08:00 | 9670985 | 1,998 | Immunity to T cell receptor peptides in multiple sclerosis. III. Preferential immunogenicity of complementarity-determining region 2 peptides from disease-associated T cell receptor BV genes. | Journal of immunology (Baltimore, Md. : 1950) | D N Bourdette; Y K Chou; R H Whitham; J Buckner; H J Kwon; G T Nepom; A Buenafe; S A Cooper; M Allegretta; G A Hashim; H Offner; A A Vandenbark | 115989 | BV5S2 33-52 | FragmentOfANaturalSequenceMolecule | Peptide from protein | SWYQQALGQGPQFIFQYYEE | 20 | null | 52 | 71 | 9606 | AAB63910.1 | null | Epitope containing region/antigenic site | Representative selection | MhcBinding | 1682188 | 273 | Table IV | Positive-Low | true | 5000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 4 |
315263.xml | 315263 | 2026-02-03-08:00 | 9670985 | 1,998 | Immunity to T cell receptor peptides in multiple sclerosis. III. Preferential immunogenicity of complementarity-determining region 2 peptides from disease-associated T cell receptor BV genes. | Journal of immunology (Baltimore, Md. : 1950) | D N Bourdette; Y K Chou; R H Whitham; J Buckner; H J Kwon; G T Nepom; A Buenafe; S A Cooper; M Allegretta; G A Hashim; H Offner; A A Vandenbark | 115683 | BV5S2 38-58 | FragmentOfANaturalSequenceMolecule | Peptide from protein | ALGQGPQFIFQYYEEEERQRG | 21 | null | 57 | 77 | 9606 | AAB63910.1 | null | Epitope containing region/antigenic site | Representative selection | TCell | 1682160 | 69 | Figures 2, 3, and 4, Tables III, V, and VI | Positive | true | null | 9606 | null | 33-66 years | DOID:2377 | 304 | null | PBMC | blood | Direct Ex Vivo | Exact match to reference information | Exact match to reference information | null | 2 |
315263.xml | 315263 | 2026-02-03-08:00 | 9670985 | 1,998 | Immunity to T cell receptor peptides in multiple sclerosis. III. Preferential immunogenicity of complementarity-determining region 2 peptides from disease-associated T cell receptor BV genes. | Journal of immunology (Baltimore, Md. : 1950) | D N Bourdette; Y K Chou; R H Whitham; J Buckner; H J Kwon; G T Nepom; A Buenafe; S A Cooper; M Allegretta; G A Hashim; H Offner; A A Vandenbark | 115683 | BV5S2 38-58 | FragmentOfANaturalSequenceMolecule | Peptide from protein | ALGQGPQFIFQYYEEEERQRG | 21 | null | 57 | 77 | 9606 | AAB63910.1 | null | Epitope containing region/antigenic site | Representative selection | MhcBinding | 1682179 | 273 | Figure 5 and Table IV | Positive-High | true | 50.0 | null | null | null | null | null | null | null | null | null | null | null | null | 2 |
315263.xml | 315263 | 2026-02-03-08:00 | 9670985 | 1,998 | Immunity to T cell receptor peptides in multiple sclerosis. III. Preferential immunogenicity of complementarity-determining region 2 peptides from disease-associated T cell receptor BV genes. | Journal of immunology (Baltimore, Md. : 1950) | D N Bourdette; Y K Chou; R H Whitham; J Buckner; H J Kwon; G T Nepom; A Buenafe; S A Cooper; M Allegretta; G A Hashim; H Offner; A A Vandenbark | 115683 | BV5S2 38-58 | FragmentOfANaturalSequenceMolecule | Peptide from protein | ALGQGPQFIFQYYEEEERQRG | 21 | null | 57 | 77 | 9606 | AAB63910.1 | null | Epitope containing region/antigenic site | Representative selection | MhcBinding | 1682189 | 273 | Figure 5 and Table IV | Positive-High | true | 100.0 | null | null | null | null | null | null | null | null | null | null | null | null | 2 |
315263.xml | 315263 | 2026-02-03-08:00 | 9670985 | 1,998 | Immunity to T cell receptor peptides in multiple sclerosis. III. Preferential immunogenicity of complementarity-determining region 2 peptides from disease-associated T cell receptor BV genes. | Journal of immunology (Baltimore, Md. : 1950) | D N Bourdette; Y K Chou; R H Whitham; J Buckner; H J Kwon; G T Nepom; A Buenafe; S A Cooper; M Allegretta; G A Hashim; H Offner; A A Vandenbark | 115936 | BV5S2 48-67 | FragmentOfANaturalSequenceMolecule | Peptide from protein | QYYEEEERQRGNFPDRFSG | 19 | null | 67 | 85 | 9606 | AAB63910.1 | null | Epitope containing region/antigenic site | Representative selection | TCell | 1682162 | 69 | Figures 2 and 3 | Negative | false | null | 9606 | null | 33-66 years | DOID:2377 | 436 | null | PBMC | blood | Direct Ex Vivo | Exact match to reference information | Exact match to reference information | null | 2 |
315263.xml | 315263 | 2026-02-03-08:00 | 9670985 | 1,998 | Immunity to T cell receptor peptides in multiple sclerosis. III. Preferential immunogenicity of complementarity-determining region 2 peptides from disease-associated T cell receptor BV genes. | Journal of immunology (Baltimore, Md. : 1950) | D N Bourdette; Y K Chou; R H Whitham; J Buckner; H J Kwon; G T Nepom; A Buenafe; S A Cooper; M Allegretta; G A Hashim; H Offner; A A Vandenbark | 115936 | BV5S2 48-67 | FragmentOfANaturalSequenceMolecule | Peptide from protein | QYYEEEERQRGNFPDRFSG | 19 | null | 67 | 85 | 9606 | AAB63910.1 | null | Epitope containing region/antigenic site | Representative selection | MhcBinding | 1682190 | 273 | Table IV | Negative | false | 10.0 | null | null | null | null | null | null | null | null | null | null | null | null | 2 |
315263.xml | 315263 | 2026-02-03-08:00 | 9670985 | 1,998 | Immunity to T cell receptor peptides in multiple sclerosis. III. Preferential immunogenicity of complementarity-determining region 2 peptides from disease-associated T cell receptor BV genes. | Journal of immunology (Baltimore, Md. : 1950) | D N Bourdette; Y K Chou; R H Whitham; J Buckner; H J Kwon; G T Nepom; A Buenafe; S A Cooper; M Allegretta; G A Hashim; H Offner; A A Vandenbark | 115936 | BV5S2 48-67 | FragmentOfANaturalSequenceMolecule | Peptide from protein | QYYEEEERQRGNFPDRFSG | 19 | null | 67 | 85 | 9606 | AAB63910.1 | null | Epitope containing region/antigenic site | Representative selection | MhcBinding | 1682180 | 273 | Table IV | Negative | false | 10000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 2 |
315263.xml | 315263 | 2026-02-03-08:00 | 9670985 | 1,998 | Immunity to T cell receptor peptides in multiple sclerosis. III. Preferential immunogenicity of complementarity-determining region 2 peptides from disease-associated T cell receptor BV genes. | Journal of immunology (Baltimore, Md. : 1950) | D N Bourdette; Y K Chou; R H Whitham; J Buckner; H J Kwon; G T Nepom; A Buenafe; S A Cooper; M Allegretta; G A Hashim; H Offner; A A Vandenbark | 115762 | BV5S2 58-78 | FragmentOfANaturalSequenceMolecule | Peptide from protein | GNFPDRFSGHQFPNYSSELN | 20 | null | 77 | 96 | 9606 | AAB63910.1 | null | Epitope containing region/antigenic site | Representative selection | TCell | 1682163 | 69 | Figures 1, 2, and 3, Table III | Negative | false | null | 9606 | null | 33-66 years | DOID:2377 | 368 | null | PBMC | blood | Direct Ex Vivo | Exact match to reference information | Exact match to reference information | null | 1 |
315263.xml | 315263 | 2026-02-03-08:00 | 9670985 | 1,998 | Immunity to T cell receptor peptides in multiple sclerosis. III. Preferential immunogenicity of complementarity-determining region 2 peptides from disease-associated T cell receptor BV genes. | Journal of immunology (Baltimore, Md. : 1950) | D N Bourdette; Y K Chou; R H Whitham; J Buckner; H J Kwon; G T Nepom; A Buenafe; S A Cooper; M Allegretta; G A Hashim; H Offner; A A Vandenbark | 115762 | BV5S2 58-78 | FragmentOfANaturalSequenceMolecule | Peptide from protein | GNFPDRFSGHQFPNYSSELN | 20 | null | 77 | 96 | 9606 | AAB63910.1 | null | Epitope containing region/antigenic site | Representative selection | MhcBinding | 1682191 | 273 | Table IV | Positive-Intermediate | true | 2000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 1 |
315263.xml | 315263 | 2026-02-03-08:00 | 9670985 | 1,998 | Immunity to T cell receptor peptides in multiple sclerosis. III. Preferential immunogenicity of complementarity-determining region 2 peptides from disease-associated T cell receptor BV genes. | Journal of immunology (Baltimore, Md. : 1950) | D N Bourdette; Y K Chou; R H Whitham; J Buckner; H J Kwon; G T Nepom; A Buenafe; S A Cooper; M Allegretta; G A Hashim; H Offner; A A Vandenbark | 115762 | BV5S2 58-78 | FragmentOfANaturalSequenceMolecule | Peptide from protein | GNFPDRFSGHQFPNYSSELN | 20 | null | 77 | 96 | 9606 | AAB63910.1 | null | Epitope containing region/antigenic site | Representative selection | MhcBinding | 1682181 | 273 | Table IV | Negative | false | 10.0 | null | null | null | null | null | null | null | null | null | null | null | null | 1 |
315263.xml | 315263 | 2026-02-03-08:00 | 9670985 | 1,998 | Immunity to T cell receptor peptides in multiple sclerosis. III. Preferential immunogenicity of complementarity-determining region 2 peptides from disease-associated T cell receptor BV genes. | Journal of immunology (Baltimore, Md. : 1950) | D N Bourdette; Y K Chou; R H Whitham; J Buckner; H J Kwon; G T Nepom; A Buenafe; S A Cooper; M Allegretta; G A Hashim; H Offner; A A Vandenbark | 115894 | BV5S2 71-89 | FragmentOfANaturalSequenceMolecule | Peptide from protein | PNYSSELNVNALLLGDSAL | 19 | null | 89 | 107 | 9606 | AAB63910.1 | null | Epitope containing region/antigenic site | Representative selection | TCell | 1682164 | 69 | Figures 2 and 3 | Negative | false | null | 9606 | null | 33-66 years | DOID:2377 | 304 | null | PBMC | blood | Direct Ex Vivo | Exact match to reference information | Exact match to reference information | null | 5 |
315263.xml | 315263 | 2026-02-03-08:00 | 9670985 | 1,998 | Immunity to T cell receptor peptides in multiple sclerosis. III. Preferential immunogenicity of complementarity-determining region 2 peptides from disease-associated T cell receptor BV genes. | Journal of immunology (Baltimore, Md. : 1950) | D N Bourdette; Y K Chou; R H Whitham; J Buckner; H J Kwon; G T Nepom; A Buenafe; S A Cooper; M Allegretta; G A Hashim; H Offner; A A Vandenbark | 115894 | BV5S2 71-89 | FragmentOfANaturalSequenceMolecule | Peptide from protein | PNYSSELNVNALLLGDSAL | 19 | null | 89 | 107 | 9606 | AAB63910.1 | null | Epitope containing region/antigenic site | Representative selection | MhcBinding | 1682192 | 273 | Table IV | Negative | false | 10.0 | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
315263.xml | 315263 | 2026-02-03-08:00 | 9670985 | 1,998 | Immunity to T cell receptor peptides in multiple sclerosis. III. Preferential immunogenicity of complementarity-determining region 2 peptides from disease-associated T cell receptor BV genes. | Journal of immunology (Baltimore, Md. : 1950) | D N Bourdette; Y K Chou; R H Whitham; J Buckner; H J Kwon; G T Nepom; A Buenafe; S A Cooper; M Allegretta; G A Hashim; H Offner; A A Vandenbark | 115894 | BV5S2 71-89 | FragmentOfANaturalSequenceMolecule | Peptide from protein | PNYSSELNVNALLLGDSAL | 19 | null | 89 | 107 | 9606 | AAB63910.1 | null | Epitope containing region/antigenic site | Representative selection | MhcBinding | 1682182 | 273 | Table IV | Negative | false | 10.0 | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
315263.xml | 315263 | 2026-02-03-08:00 | 9670985 | 1,998 | Immunity to T cell receptor peptides in multiple sclerosis. III. Preferential immunogenicity of complementarity-determining region 2 peptides from disease-associated T cell receptor BV genes. | Journal of immunology (Baltimore, Md. : 1950) | D N Bourdette; Y K Chou; R H Whitham; J Buckner; H J Kwon; G T Nepom; A Buenafe; S A Cooper; M Allegretta; G A Hashim; H Offner; A A Vandenbark | 115867 | BV5S2 80-95 | FragmentOfANaturalSequenceMolecule | Peptide from protein | NALLLGDSALYLCASS | 16 | null | 98 | 113 | 9606 | AAB63910.1 | null | Epitope containing region/antigenic site | Representative selection | TCell | 1682165 | 69 | Figures 2 and 3 | Negative | false | null | 9606 | null | 33-66 years | DOID:2377 | 368 | null | PBMC | blood | Direct Ex Vivo | Exact match to reference information | Exact match to reference information | null | 8 |
315263.xml | 315263 | 2026-02-03-08:00 | 9670985 | 1,998 | Immunity to T cell receptor peptides in multiple sclerosis. III. Preferential immunogenicity of complementarity-determining region 2 peptides from disease-associated T cell receptor BV genes. | Journal of immunology (Baltimore, Md. : 1950) | D N Bourdette; Y K Chou; R H Whitham; J Buckner; H J Kwon; G T Nepom; A Buenafe; S A Cooper; M Allegretta; G A Hashim; H Offner; A A Vandenbark | 115867 | BV5S2 80-95 | FragmentOfANaturalSequenceMolecule | Peptide from protein | NALLLGDSALYLCASS | 16 | null | 98 | 113 | 9606 | AAB63910.1 | null | Epitope containing region/antigenic site | Representative selection | MhcBinding | 1682193 | 273 | Table IV | Positive-Intermediate | true | 2000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 8 |
315263.xml | 315263 | 2026-02-03-08:00 | 9670985 | 1,998 | Immunity to T cell receptor peptides in multiple sclerosis. III. Preferential immunogenicity of complementarity-determining region 2 peptides from disease-associated T cell receptor BV genes. | Journal of immunology (Baltimore, Md. : 1950) | D N Bourdette; Y K Chou; R H Whitham; J Buckner; H J Kwon; G T Nepom; A Buenafe; S A Cooper; M Allegretta; G A Hashim; H Offner; A A Vandenbark | 115962 | BV9 38-58 | FragmentOfANaturalSequenceMolecule | Peptide from protein | SKKFLKIMFSYNNKELIINET | 21 | null | 65 | 85 | 9606 | BAF94979.1 | null | Epitope containing region/antigenic site | Representative selection | TCell | 1682167 | 69 | Table III | Positive | true | null | 9606 | null | 33-66 years | DOID:2377 | 304 | null | PBMC | blood | Direct Ex Vivo | Exact match to reference information | Exact match to reference information | null | 2 |
315263.xml | 315263 | 2026-02-03-08:00 | 9670985 | 1,998 | Immunity to T cell receptor peptides in multiple sclerosis. III. Preferential immunogenicity of complementarity-determining region 2 peptides from disease-associated T cell receptor BV genes. | Journal of immunology (Baltimore, Md. : 1950) | D N Bourdette; Y K Chou; R H Whitham; J Buckner; H J Kwon; G T Nepom; A Buenafe; S A Cooper; M Allegretta; G A Hashim; H Offner; A A Vandenbark | 115861 | BV3 11-30 | FragmentOfANaturalSequenceMolecule | Peptide from protein | LVKRTGEKVFLECVQDMDHE | 20 | null | 33 | 52 | 9606 | BAF94971.1 | null | Epitope containing region/antigenic site | Representative selection | TCell | 1682168 | 69 | Table III | Negative | false | null | 9606 | null | 33-66 years | DOID:2377 | 304 | null | PBMC | blood | Direct Ex Vivo | Exact match to reference information | Exact match to reference information | null | 9 |
315263.xml | 315263 | 2026-02-03-08:00 | 9670985 | 1,998 | Immunity to T cell receptor peptides in multiple sclerosis. III. Preferential immunogenicity of complementarity-determining region 2 peptides from disease-associated T cell receptor BV genes. | Journal of immunology (Baltimore, Md. : 1950) | D N Bourdette; Y K Chou; R H Whitham; J Buckner; H J Kwon; G T Nepom; A Buenafe; S A Cooper; M Allegretta; G A Hashim; H Offner; A A Vandenbark | 115714 | BV3 38-58 | FragmentOfANaturalSequenceMolecule | Peptide from protein | DPGLGLRLIYFSYDVKMKEKG | 21 | null | 60 | 80 | 9606 | BAF94971.1 | null | Epitope containing region/antigenic site | Representative selection | TCell | 1682169 | 69 | Table III | Positive | true | null | 9606 | null | 33-66 years | DOID:2377 | 304 | null | PBMC | blood | Direct Ex Vivo | Exact match to reference information | Exact match to reference information | null | 1 |
315263.xml | 315263 | 2026-02-03-08:00 | 9670985 | 1,998 | Immunity to T cell receptor peptides in multiple sclerosis. III. Preferential immunogenicity of complementarity-determining region 2 peptides from disease-associated T cell receptor BV genes. | Journal of immunology (Baltimore, Md. : 1950) | D N Bourdette; Y K Chou; R H Whitham; J Buckner; H J Kwon; G T Nepom; A Buenafe; S A Cooper; M Allegretta; G A Hashim; H Offner; A A Vandenbark | 115713 | BV12S2 38-58 | FragmentOfANaturalSequenceMolecule | Peptide from protein | DPGHGLRLIHYSYGVKDTDKG | 21 | null | 63 | 83 | 9606 | BAF94934.1 | null | Epitope containing region/antigenic site | Representative selection | TCell | 1682170 | 69 | Table III | Positive | true | null | 9606 | null | 33-66 years | DOID:2377 | 304 | null | PBMC | blood | Direct Ex Vivo | Exact match to reference information | Exact match to reference information | null | 5 |
315263.xml | 315263 | 2026-02-03-08:00 | 9670985 | 1,998 | Immunity to T cell receptor peptides in multiple sclerosis. III. Preferential immunogenicity of complementarity-determining region 2 peptides from disease-associated T cell receptor BV genes. | Journal of immunology (Baltimore, Md. : 1950) | D N Bourdette; Y K Chou; R H Whitham; J Buckner; H J Kwon; G T Nepom; A Buenafe; S A Cooper; M Allegretta; G A Hashim; H Offner; A A Vandenbark | 115682 | BV5S2 38-58(Y49T) | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ALGQGPQFIFQTYEEEERQRG | 21 | null | null | null | null | null | null | Epitope containing region/antigenic site | Exact match to reference information | TCell | 1683129 | 69 | Figures 2, 3, and 4, Table III | Positive | true | null | 9606 | null | 33-66 years | DOID:2377 | 304 | null | PBMC | blood | Direct Ex Vivo | Exact match to reference information | Exact match to reference information | null | 3 |
315263.xml | 315263 | 2026-02-03-08:00 | 9670985 | 1,998 | Immunity to T cell receptor peptides in multiple sclerosis. III. Preferential immunogenicity of complementarity-determining region 2 peptides from disease-associated T cell receptor BV genes. | Journal of immunology (Baltimore, Md. : 1950) | D N Bourdette; Y K Chou; R H Whitham; J Buckner; H J Kwon; G T Nepom; A Buenafe; S A Cooper; M Allegretta; G A Hashim; H Offner; A A Vandenbark | 115682 | BV5S2 38-58(Y49T) | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ALGQGPQFIFQTYEEEERQRG | 21 | null | null | null | null | null | null | Epitope containing region/antigenic site | Exact match to reference information | TCell | 1683130 | 69 | Table VI | Positive | true | null | 9606 | null | 33-66 years | DOID:2377 | 304 | null | PBMC | blood | Short Term Restimulated | Exact match to reference information | Exact match to reference information | null | 3 |
315266.xml | 315266 | 2025-11-06-08:00 | 9725236 | 1,998 | CTL response to Mycobacterium tuberculosis: identification of an immunogenic epitope in the 19-kDa lipoprotein. | Journal of immunology (Baltimore, Md. : 1950) | N Mohagheghpour; D Gammon; L M Kawamura; A van Vollenhoven; C J Benike; E G Engleman | 69798 | M.tb19 (88-97) | FragmentOfANaturalSequenceMolecule | Peptide from protein | VLTDGNPPEV | 10 | null | 88 | 97 | 1773 | NP_338420.1 | null | Exact Epitope | Representative selection | TCell | 1031564 | 67 | Figure 3 | Positive | true | null | 9606 | null | null | DOID:399 | 143 | null | T cell CD8+ | blood | Cell Line / Clone | Exact match to reference information | Representative selection | null | 4 |
315266.xml | 315266 | 2025-11-06-08:00 | 9725236 | 1,998 | CTL response to Mycobacterium tuberculosis: identification of an immunogenic epitope in the 19-kDa lipoprotein. | Journal of immunology (Baltimore, Md. : 1950) | N Mohagheghpour; D Gammon; L M Kawamura; A van Vollenhoven; C J Benike; E G Engleman | 69798 | M.tb19 (88-97) | FragmentOfANaturalSequenceMolecule | Peptide from protein | VLTDGNPPEV | 10 | null | 88 | 97 | 1773 | NP_338420.1 | null | Exact Epitope | Representative selection | TCell | 1031565 | 67 | Figure 5 | Positive | true | null | 9606 | null | null | null | 143 | null | T cell CD8+ | blood | Cell Line / Clone | Exact match to reference information | Exact match to reference information | null | 4 |
315266.xml | 315266 | 2025-11-06-08:00 | 9725236 | 1,998 | CTL response to Mycobacterium tuberculosis: identification of an immunogenic epitope in the 19-kDa lipoprotein. | Journal of immunology (Baltimore, Md. : 1950) | N Mohagheghpour; D Gammon; L M Kawamura; A van Vollenhoven; C J Benike; E G Engleman | 69798 | M.tb19 (88-97) | FragmentOfANaturalSequenceMolecule | Peptide from protein | VLTDGNPPEV | 10 | null | 88 | 97 | 1773 | NP_338420.1 | null | Exact Epitope | Representative selection | TCell | 316488 | 67 | Figure 2 | Positive | true | null | 9606 | null | null | ONTIE:0003423 | 143 | null | T cell CD8+ | blood | Cell Line / Clone | Exact match to reference information | Representative selection | null | 4 |
315266.xml | 315266 | 2025-11-06-08:00 | 9725236 | 1,998 | CTL response to Mycobacterium tuberculosis: identification of an immunogenic epitope in the 19-kDa lipoprotein. | Journal of immunology (Baltimore, Md. : 1950) | N Mohagheghpour; D Gammon; L M Kawamura; A van Vollenhoven; C J Benike; E G Engleman | 69798 | M.tb19 (88-97) | FragmentOfANaturalSequenceMolecule | Peptide from protein | VLTDGNPPEV | 10 | null | 88 | 97 | 1773 | NP_338420.1 | null | Exact Epitope | Representative selection | TCell | 1866162 | 67 | Figure 6 | Positive | true | null | 9606 | null | null | null | 143 | null | T cell CD8+ | blood | Cell Line / Clone | Representative selection | Exact match to reference information | null | 4 |
315266.xml | 315266 | 2025-11-06-08:00 | 9725236 | 1,998 | CTL response to Mycobacterium tuberculosis: identification of an immunogenic epitope in the 19-kDa lipoprotein. | Journal of immunology (Baltimore, Md. : 1950) | N Mohagheghpour; D Gammon; L M Kawamura; A van Vollenhoven; C J Benike; E G Engleman | 69798 | M.tb19 (88-97) | FragmentOfANaturalSequenceMolecule | Peptide from protein | VLTDGNPPEV | 10 | null | 88 | 97 | 1773 | NP_338420.1 | null | Exact Epitope | Representative selection | TCell | 1866163 | 67 | Figure 6 | Positive | true | null | 9606 | null | null | null | 143 | null | T cell CD8+ | blood | Cell Line / Clone | Representative selection | Representative selection | null | 4 |
315266.xml | 315266 | 2025-11-06-08:00 | 9725236 | 1,998 | CTL response to Mycobacterium tuberculosis: identification of an immunogenic epitope in the 19-kDa lipoprotein. | Journal of immunology (Baltimore, Md. : 1950) | N Mohagheghpour; D Gammon; L M Kawamura; A van Vollenhoven; C J Benike; E G Engleman | 69798 | M.tb19 (88-97) | FragmentOfANaturalSequenceMolecule | Peptide from protein | VLTDGNPPEV | 10 | null | 88 | 97 | 1773 | NP_338420.1 | null | Exact Epitope | Representative selection | MhcBinding | 1031563 | 185 | Table II and figure 1 | Positive-High | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 4 |
315266.xml | 315266 | 2025-11-06-08:00 | 9725236 | 1,998 | CTL response to Mycobacterium tuberculosis: identification of an immunogenic epitope in the 19-kDa lipoprotein. | Journal of immunology (Baltimore, Md. : 1950) | N Mohagheghpour; D Gammon; L M Kawamura; A van Vollenhoven; C J Benike; E G Engleman | 156671 | M.tb19 (4-12) | FragmentOfANaturalSequenceMolecule | Peptide from protein | GLTVAVAGA | 9 | null | 4 | 12 | 1773 | NP_338420.1 | null | Exact Epitope | Representative selection | MhcBinding | 1866119 | 185 | Table II | Positive-Intermediate | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
315266.xml | 315266 | 2025-11-06-08:00 | 9725236 | 1,998 | CTL response to Mycobacterium tuberculosis: identification of an immunogenic epitope in the 19-kDa lipoprotein. | Journal of immunology (Baltimore, Md. : 1950) | N Mohagheghpour; D Gammon; L M Kawamura; A van Vollenhoven; C J Benike; E G Engleman | 156691 | M.tb19 (14-22) | FragmentOfANaturalSequenceMolecule | Peptide from protein | ILVAGLSGC | 9 | null | 14 | 22 | 1773 | NP_338420.1 | null | Exact Epitope | Representative selection | MhcBinding | 1866123 | 185 | Table II | Positive-High | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
315266.xml | 315266 | 2025-11-06-08:00 | 9725236 | 1,998 | CTL response to Mycobacterium tuberculosis: identification of an immunogenic epitope in the 19-kDa lipoprotein. | Journal of immunology (Baltimore, Md. : 1950) | N Mohagheghpour; D Gammon; L M Kawamura; A van Vollenhoven; C J Benike; E G Engleman | 156669 | M.tb19 (101-108) | FragmentOfANaturalSequenceMolecule | Peptide from protein | GLGNVNGV | 8 | null | 101 | 108 | 1773 | NP_338420.1 | null | Exact Epitope | Representative selection | MhcBinding | 1866127 | 185 | Table II | Positive-Intermediate | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 1 |
315266.xml | 315266 | 2025-11-06-08:00 | 9725236 | 1,998 | CTL response to Mycobacterium tuberculosis: identification of an immunogenic epitope in the 19-kDa lipoprotein. | Journal of immunology (Baltimore, Md. : 1950) | N Mohagheghpour; D Gammon; L M Kawamura; A van Vollenhoven; C J Benike; E G Engleman | 156699 | M.tb19 (131-139) | FragmentOfANaturalSequenceMolecule | Peptide from protein | KITGTATGV | 9 | null | 131 | 139 | 1773 | NP_338420.1 | null | Exact Epitope | Representative selection | MhcBinding | 1866131 | 185 | Table II | Positive-Intermediate | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
315266.xml | 315266 | 2025-11-06-08:00 | 9725236 | 1,998 | CTL response to Mycobacterium tuberculosis: identification of an immunogenic epitope in the 19-kDa lipoprotein. | Journal of immunology (Baltimore, Md. : 1950) | N Mohagheghpour; D Gammon; L M Kawamura; A van Vollenhoven; C J Benike; E G Engleman | 156606 | M.tb19 (77-85) | FragmentOfANaturalSequenceMolecule | Peptide from protein | AIGGAATGI | 9 | null | 77 | 85 | 1773 | NP_338420.1 | null | Exact Epitope | Representative selection | MhcBinding | 1866139 | 185 | Table II | Positive-Low | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
315268.xml | 315268 | 2026-02-03-08:00 | 9739058 | 1,998 | Enhanced in vitro potency and in vivo immunogenicity of a CTL epitope from hepatitis C virus core protein following amino acid replacement at secondary HLA-A2.1 binding positions. | The Journal of clinical investigation | P Sarobe; C D Pendleton; T Akatsuka; D Lau; V H Engelhard; S M Feinstone; J A Berzofsky | 9203 | C7A2-WT | FragmentOfANaturalSequenceMolecule | Peptide from protein | DLMGYIPLV | 9 | null | 132 | 140 | 3052230 | BAB18806.1 | null | Exact Epitope | Not determined | TCell | 1421052 | 67 | Figures 3, 4, 5, 6, 7, and 8 | Positive | true | null | 10000582 | null | 8-12 weeks | null | 143 | null | T cell | spleen | Cell Line / Clone | Exact match to reference information | Exact match to reference information | null | 4 |
315268.xml | 315268 | 2026-02-03-08:00 | 9739058 | 1,998 | Enhanced in vitro potency and in vivo immunogenicity of a CTL epitope from hepatitis C virus core protein following amino acid replacement at secondary HLA-A2.1 binding positions. | The Journal of clinical investigation | P Sarobe; C D Pendleton; T Akatsuka; D Lau; V H Engelhard; S M Feinstone; J A Berzofsky | 9203 | C7A2-WT | FragmentOfANaturalSequenceMolecule | Peptide from protein | DLMGYIPLV | 9 | null | 132 | 140 | 3052230 | BAB18806.1 | null | Exact Epitope | Not determined | TCell | 1315263 | 67 | Figure 2 | Positive | true | null | 9606 | null | null | DOID:1883 | 143 | null | T cell | blood | Cell Line / Clone | Exact match to reference information | Not determined | null | 4 |
315268.xml | 315268 | 2026-02-03-08:00 | 9739058 | 1,998 | Enhanced in vitro potency and in vivo immunogenicity of a CTL epitope from hepatitis C virus core protein following amino acid replacement at secondary HLA-A2.1 binding positions. | The Journal of clinical investigation | P Sarobe; C D Pendleton; T Akatsuka; D Lau; V H Engelhard; S M Feinstone; J A Berzofsky | 9203 | C7A2-WT | FragmentOfANaturalSequenceMolecule | Peptide from protein | DLMGYIPLV | 9 | null | 132 | 140 | 3052230 | BAB18806.1 | null | Exact Epitope | Not determined | MhcBinding | 1315264 | 185 | Figure 1 | Positive | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 4 |
315268.xml | 315268 | 2026-02-03-08:00 | 9739058 | 1,998 | Enhanced in vitro potency and in vivo immunogenicity of a CTL epitope from hepatitis C virus core protein following amino acid replacement at secondary HLA-A2.1 binding positions. | The Journal of clinical investigation | P Sarobe; C D Pendleton; T Akatsuka; D Lau; V H Engelhard; S M Feinstone; J A Berzofsky | 2755 | 1A | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ALMGYIPLV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 1315413 | 185 | Figure 1 | Positive | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
315268.xml | 315268 | 2026-02-03-08:00 | 9739058 | 1,998 | Enhanced in vitro potency and in vivo immunogenicity of a CTL epitope from hepatitis C virus core protein following amino acid replacement at secondary HLA-A2.1 binding positions. | The Journal of clinical investigation | P Sarobe; C D Pendleton; T Akatsuka; D Lau; V H Engelhard; S M Feinstone; J A Berzofsky | 7590 | 2A | SequenceMoleculeNoNaturalSource | Peptide, no natural source | DAMGYLPLV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 1315415 | 185 | Figure 1 | Negative | false | null | null | null | null | null | null | null | null | null | null | null | null | null | 1 |
315268.xml | 315268 | 2026-02-03-08:00 | 9739058 | 1,998 | Enhanced in vitro potency and in vivo immunogenicity of a CTL epitope from hepatitis C virus core protein following amino acid replacement at secondary HLA-A2.1 binding positions. | The Journal of clinical investigation | P Sarobe; C D Pendleton; T Akatsuka; D Lau; V H Engelhard; S M Feinstone; J A Berzofsky | 9017 | 3A | SequenceMoleculeNoNaturalSource | Peptide, no natural source | DLAGYLPLV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 1315417 | 185 | Figure 1 | Positive | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 2 |
315268.xml | 315268 | 2026-02-03-08:00 | 9739058 | 1,998 | Enhanced in vitro potency and in vivo immunogenicity of a CTL epitope from hepatitis C virus core protein following amino acid replacement at secondary HLA-A2.1 binding positions. | The Journal of clinical investigation | P Sarobe; C D Pendleton; T Akatsuka; D Lau; V H Engelhard; S M Feinstone; J A Berzofsky | 9194 | 4A | SequenceMoleculeNoNaturalSource | Peptide, no natural source | DLMAYIPLV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 1315419 | 185 | Figure 1 | Positive | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
315268.xml | 315268 | 2026-02-03-08:00 | 9739058 | 1,998 | Enhanced in vitro potency and in vivo immunogenicity of a CTL epitope from hepatitis C virus core protein following amino acid replacement at secondary HLA-A2.1 binding positions. | The Journal of clinical investigation | P Sarobe; C D Pendleton; T Akatsuka; D Lau; V H Engelhard; S M Feinstone; J A Berzofsky | 9195 | 5A | SequenceMoleculeNoNaturalSource | Peptide, no natural source | DLMGAIPLV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 1315420 | 185 | Figure 1 | Positive | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
315268.xml | 315268 | 2026-02-03-08:00 | 9739058 | 1,998 | Enhanced in vitro potency and in vivo immunogenicity of a CTL epitope from hepatitis C virus core protein following amino acid replacement at secondary HLA-A2.1 binding positions. | The Journal of clinical investigation | P Sarobe; C D Pendleton; T Akatsuka; D Lau; V H Engelhard; S M Feinstone; J A Berzofsky | 9196 | 6A | SequenceMoleculeNoNaturalSource | Peptide, no natural source | DLMGYAPLV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 1315423 | 185 | Figure 1 | Negative | false | null | null | null | null | null | null | null | null | null | null | null | null | null | 1 |
315268.xml | 315268 | 2026-02-03-08:00 | 9739058 | 1,998 | Enhanced in vitro potency and in vivo immunogenicity of a CTL epitope from hepatitis C virus core protein following amino acid replacement at secondary HLA-A2.1 binding positions. | The Journal of clinical investigation | P Sarobe; C D Pendleton; T Akatsuka; D Lau; V H Engelhard; S M Feinstone; J A Berzofsky | 9197 | 7A | SequenceMoleculeNoNaturalSource | Peptide, no natural source | DLMGYIALV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 1315424 | 185 | Figure 1 | Negative | false | null | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
315268.xml | 315268 | 2026-02-03-08:00 | 9739058 | 1,998 | Enhanced in vitro potency and in vivo immunogenicity of a CTL epitope from hepatitis C virus core protein following amino acid replacement at secondary HLA-A2.1 binding positions. | The Journal of clinical investigation | P Sarobe; C D Pendleton; T Akatsuka; D Lau; V H Engelhard; S M Feinstone; J A Berzofsky | 9201 | 9A | SequenceMoleculeNoNaturalSource | Peptide, no natural source | DLMGYIPLA | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 1315429 | 185 | Figure 1 | Negative | false | null | null | null | null | null | null | null | null | null | null | null | null | null | 1 |
315268.xml | 315268 | 2026-02-03-08:00 | 9739058 | 1,998 | Enhanced in vitro potency and in vivo immunogenicity of a CTL epitope from hepatitis C virus core protein following amino acid replacement at secondary HLA-A2.1 binding positions. | The Journal of clinical investigation | P Sarobe; C D Pendleton; T Akatsuka; D Lau; V H Engelhard; S M Feinstone; J A Berzofsky | 44804 | 1N | SequenceMoleculeNoNaturalSource | Peptide, no natural source | NLMGYIPLV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 1316258 | 185 | Figure 1 | Positive | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
315268.xml | 315268 | 2026-02-03-08:00 | 9739058 | 1,998 | Enhanced in vitro potency and in vivo immunogenicity of a CTL epitope from hepatitis C virus core protein following amino acid replacement at secondary HLA-A2.1 binding positions. | The Journal of clinical investigation | P Sarobe; C D Pendleton; T Akatsuka; D Lau; V H Engelhard; S M Feinstone; J A Berzofsky | 16768 | 1F | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FLMGYIPLV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 1316259 | 185 | Figure 1 | Positive | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 4 |
315268.xml | 315268 | 2026-02-03-08:00 | 9739058 | 1,998 | Enhanced in vitro potency and in vivo immunogenicity of a CTL epitope from hepatitis C virus core protein following amino acid replacement at secondary HLA-A2.1 binding positions. | The Journal of clinical investigation | P Sarobe; C D Pendleton; T Akatsuka; D Lau; V H Engelhard; S M Feinstone; J A Berzofsky | 24255 | 1H | SequenceMoleculeNoNaturalSource | Peptide, no natural source | HLMGYIPLV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 1315437 | 185 | Figure 1 | Positive | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
315268.xml | 315268 | 2026-02-03-08:00 | 9739058 | 1,998 | Enhanced in vitro potency and in vivo immunogenicity of a CTL epitope from hepatitis C virus core protein following amino acid replacement at secondary HLA-A2.1 binding positions. | The Journal of clinical investigation | P Sarobe; C D Pendleton; T Akatsuka; D Lau; V H Engelhard; S M Feinstone; J A Berzofsky | 59343 | 1S | SequenceMoleculeNoNaturalSource | Peptide, no natural source | SLMGYIPLV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 1316261 | 185 | Figure 1 | Positive | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
315268.xml | 315268 | 2026-02-03-08:00 | 9739058 | 1,998 | Enhanced in vitro potency and in vivo immunogenicity of a CTL epitope from hepatitis C virus core protein following amino acid replacement at secondary HLA-A2.1 binding positions. | The Journal of clinical investigation | P Sarobe; C D Pendleton; T Akatsuka; D Lau; V H Engelhard; S M Feinstone; J A Berzofsky | 64952 | 1T | SequenceMoleculeNoNaturalSource | Peptide, no natural source | TLMGYIPLV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 1316262 | 185 | Figure 1 | Positive | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 9 |
315268.xml | 315268 | 2026-02-03-08:00 | 9739058 | 1,998 | Enhanced in vitro potency and in vivo immunogenicity of a CTL epitope from hepatitis C virus core protein following amino acid replacement at secondary HLA-A2.1 binding positions. | The Journal of clinical investigation | P Sarobe; C D Pendleton; T Akatsuka; D Lau; V H Engelhard; S M Feinstone; J A Berzofsky | 9127 | 3I | SequenceMoleculeNoNaturalSource | Peptide, no natural source | DLIGYIPLV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 1316265 | 185 | Figure 1 | Positive | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 2 |
315268.xml | 315268 | 2026-02-03-08:00 | 9739058 | 1,998 | Enhanced in vitro potency and in vivo immunogenicity of a CTL epitope from hepatitis C virus core protein following amino acid replacement at secondary HLA-A2.1 binding positions. | The Journal of clinical investigation | P Sarobe; C D Pendleton; T Akatsuka; D Lau; V H Engelhard; S M Feinstone; J A Berzofsky | 9174 | 3L | SequenceMoleculeNoNaturalSource | Peptide, no natural source | DLLGYIPLV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 1316267 | 185 | Figure 1 | Positive | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 4 |
315268.xml | 315268 | 2026-02-03-08:00 | 9739058 | 1,998 | Enhanced in vitro potency and in vivo immunogenicity of a CTL epitope from hepatitis C virus core protein following amino acid replacement at secondary HLA-A2.1 binding positions. | The Journal of clinical investigation | P Sarobe; C D Pendleton; T Akatsuka; D Lau; V H Engelhard; S M Feinstone; J A Berzofsky | 9317 | 3V | SequenceMoleculeNoNaturalSource | Peptide, no natural source | DLVGYIPLV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 1316268 | 185 | Figure 1 | Positive | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 2 |
315268.xml | 315268 | 2026-02-03-08:00 | 9739058 | 1,998 | Enhanced in vitro potency and in vivo immunogenicity of a CTL epitope from hepatitis C virus core protein following amino acid replacement at secondary HLA-A2.1 binding positions. | The Journal of clinical investigation | P Sarobe; C D Pendleton; T Akatsuka; D Lau; V H Engelhard; S M Feinstone; J A Berzofsky | 9146 | 3K | SequenceMoleculeNoNaturalSource | Peptide, no natural source | DLKGYIPLV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 1316270 | 185 | Figure 1 | Positive | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
315268.xml | 315268 | 2026-02-03-08:00 | 9739058 | 1,998 | Enhanced in vitro potency and in vivo immunogenicity of a CTL epitope from hepatitis C virus core protein following amino acid replacement at secondary HLA-A2.1 binding positions. | The Journal of clinical investigation | P Sarobe; C D Pendleton; T Akatsuka; D Lau; V H Engelhard; S M Feinstone; J A Berzofsky | 9331 | 3W | SequenceMoleculeNoNaturalSource | Peptide, no natural source | DLWGYIPLV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 1316272 | 185 | Figure 1 | Positive | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 8 |
315268.xml | 315268 | 2026-02-03-08:00 | 9739058 | 1,998 | Enhanced in vitro potency and in vivo immunogenicity of a CTL epitope from hepatitis C virus core protein following amino acid replacement at secondary HLA-A2.1 binding positions. | The Journal of clinical investigation | P Sarobe; C D Pendleton; T Akatsuka; D Lau; V H Engelhard; S M Feinstone; J A Berzofsky | 9198 | 7G | SequenceMoleculeNoNaturalSource | Peptide, no natural source | DLMGYIGLV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 1316274 | 185 | Figure 1 | Positive | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 1 |
315268.xml | 315268 | 2026-02-03-08:00 | 9739058 | 1,998 | Enhanced in vitro potency and in vivo immunogenicity of a CTL epitope from hepatitis C virus core protein following amino acid replacement at secondary HLA-A2.1 binding positions. | The Journal of clinical investigation | P Sarobe; C D Pendleton; T Akatsuka; D Lau; V H Engelhard; S M Feinstone; J A Berzofsky | 9208 | 7V | SequenceMoleculeNoNaturalSource | Peptide, no natural source | DLMGYIVLV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 1316277 | 185 | Figure 1 | Positive | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 2 |
315268.xml | 315268 | 2026-02-03-08:00 | 9739058 | 1,998 | Enhanced in vitro potency and in vivo immunogenicity of a CTL epitope from hepatitis C virus core protein following amino acid replacement at secondary HLA-A2.1 binding positions. | The Journal of clinical investigation | P Sarobe; C D Pendleton; T Akatsuka; D Lau; V H Engelhard; S M Feinstone; J A Berzofsky | 9207 | 8V | SequenceMoleculeNoNaturalSource | Peptide, no natural source | DLMGYIPVV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 1316278 | 185 | Figure 1 | Positive | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
315268.xml | 315268 | 2026-02-03-08:00 | 9739058 | 1,998 | Enhanced in vitro potency and in vivo immunogenicity of a CTL epitope from hepatitis C virus core protein following amino acid replacement at secondary HLA-A2.1 binding positions. | The Journal of clinical investigation | P Sarobe; C D Pendleton; T Akatsuka; D Lau; V H Engelhard; S M Feinstone; J A Berzofsky | 9199 | null | FragmentOfANaturalSequenceMolecule | Peptide from protein | DLMGYIPAV | 9 | null | 16 | 24 | 3052230 | ABB77003.1 | null | Exact Epitope | null | MhcBinding | 22756396 | 185 | Figure 1 | Positive | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
315269.xml | 315269 | 2025-11-06-08:00 | 9743387 | 1,998 | Generation of human cytolytic T lymphocyte lines directed against prostate-specific antigen (PSA) employing a PSA oligoepitope peptide. | Journal of immunology (Baltimore, Md. : 1950) | P Correale; K Walmsley; S Zaremba; M Zhu; J Schlom; K Y Tsang | 989936 | PSA-2 | FragmentOfANaturalSequenceMolecule | Peptide from protein | KLQCVDLHV | 9 | null | 170 | 178 | 9606 | P07288.2 | null | Exact Epitope | null | MhcBinding | 17307900 | 185 | Table I | Positive | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
315269.xml | 315269 | 2025-11-06-08:00 | 9743387 | 1,998 | Generation of human cytolytic T lymphocyte lines directed against prostate-specific antigen (PSA) employing a PSA oligoepitope peptide. | Journal of immunology (Baltimore, Md. : 1950) | P Correale; K Walmsley; S Zaremba; M Zhu; J Schlom; K Y Tsang | 111916 | PSA-3 | FragmentOfANaturalSequenceMolecule | Peptide from protein | VISNDVCAQV | 10 | null | 178 | 187 | 9606 | P07288.2 | null | Exact Epitope | null | TCell | 17307892 | 135 | Table VIII | Positive | true | null | 10000576 | null | null | null | 235 | 235 | splenocyte | spleen | Direct Ex Vivo | Exact match to reference information | Exact match to reference information | null | 7 |
315269.xml | 315269 | 2025-11-06-08:00 | 9743387 | 1,998 | Generation of human cytolytic T lymphocyte lines directed against prostate-specific antigen (PSA) employing a PSA oligoepitope peptide. | Journal of immunology (Baltimore, Md. : 1950) | P Correale; K Walmsley; S Zaremba; M Zhu; J Schlom; K Y Tsang | 111916 | PSA-3 | FragmentOfANaturalSequenceMolecule | Peptide from protein | VISNDVCAQV | 10 | null | 178 | 187 | 9606 | P07288.2 | null | Exact Epitope | null | TCell | 17599344 | 135 | Table IX, Table II | Positive | true | null | 9606 | null | null | null | 235 | 235 | T cell | blood | Cell Line / Clone | Exact match to reference information | Exact match to reference information | null | 7 |
315269.xml | 315269 | 2025-11-06-08:00 | 9743387 | 1,998 | Generation of human cytolytic T lymphocyte lines directed against prostate-specific antigen (PSA) employing a PSA oligoepitope peptide. | Journal of immunology (Baltimore, Md. : 1950) | P Correale; K Walmsley; S Zaremba; M Zhu; J Schlom; K Y Tsang | 111916 | PSA-3 | FragmentOfANaturalSequenceMolecule | Peptide from protein | VISNDVCAQV | 10 | null | 178 | 187 | 9606 | P07288.2 | null | Exact Epitope | null | TCell | 16583020 | 135 | Figure 1, Figure 3 | Positive | true | null | 9606 | null | null | null | 235 | 235 | T cell | blood | Cell Line / Clone | Exact match to reference information | Exact match to reference information | null | 7 |
315269.xml | 315269 | 2025-11-06-08:00 | 9743387 | 1,998 | Generation of human cytolytic T lymphocyte lines directed against prostate-specific antigen (PSA) employing a PSA oligoepitope peptide. | Journal of immunology (Baltimore, Md. : 1950) | P Correale; K Walmsley; S Zaremba; M Zhu; J Schlom; K Y Tsang | 111916 | PSA-3 | FragmentOfANaturalSequenceMolecule | Peptide from protein | VISNDVCAQV | 10 | null | 178 | 187 | 9606 | P07288.2 | null | Exact Epitope | null | MhcBinding | 17307901 | 185 | Table I | Positive | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
315269.xml | 315269 | 2025-11-06-08:00 | 9743387 | 1,998 | Generation of human cytolytic T lymphocyte lines directed against prostate-specific antigen (PSA) employing a PSA oligoepitope peptide. | Journal of immunology (Baltimore, Md. : 1950) | P Correale; K Walmsley; S Zaremba; M Zhu; J Schlom; K Y Tsang | 111916 | PSA-3 | FragmentOfANaturalSequenceMolecule | Peptide from protein | VISNDVCAQV | 10 | null | 178 | 187 | 9606 | P07288.2 | null | Exact Epitope | null | MhcBinding | 17307905 | 185 | Table I | Negative | false | null | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
315269.xml | 315269 | 2025-11-06-08:00 | 9743387 | 1,998 | Generation of human cytolytic T lymphocyte lines directed against prostate-specific antigen (PSA) employing a PSA oligoepitope peptide. | Journal of immunology (Baltimore, Md. : 1950) | P Correale; K Walmsley; S Zaremba; M Zhu; J Schlom; K Y Tsang | 1859267 | PSA-9 | FragmentOfANaturalSequenceMolecule | Peptide from protein | QVHPQKVTK | 9 | null | 186 | 194 | 9606 | P07288.2 | null | Exact Epitope | null | TCell | 17599343 | 135 | Table III | Positive | true | null | 9606 | null | null | null | 242 | 242 | T cell | blood | Cell Line / Clone | Exact match to reference information | Exact match to reference information | null | 4 |
315269.xml | 315269 | 2025-11-06-08:00 | 9743387 | 1,998 | Generation of human cytolytic T lymphocyte lines directed against prostate-specific antigen (PSA) employing a PSA oligoepitope peptide. | Journal of immunology (Baltimore, Md. : 1950) | P Correale; K Walmsley; S Zaremba; M Zhu; J Schlom; K Y Tsang | 1859267 | PSA-9 | FragmentOfANaturalSequenceMolecule | Peptide from protein | QVHPQKVTK | 9 | null | 186 | 194 | 9606 | P07288.2 | null | Exact Epitope | null | TCell | 16583022 | 135 | Figure 2, Figure 4 | Positive | true | null | 9606 | null | null | null | 242 | 242 | T cell | blood | Cell Line / Clone | Exact match to reference information | Exact match to reference information | null | 4 |
315269.xml | 315269 | 2025-11-06-08:00 | 9743387 | 1,998 | Generation of human cytolytic T lymphocyte lines directed against prostate-specific antigen (PSA) employing a PSA oligoepitope peptide. | Journal of immunology (Baltimore, Md. : 1950) | P Correale; K Walmsley; S Zaremba; M Zhu; J Schlom; K Y Tsang | 1859267 | PSA-9 | FragmentOfANaturalSequenceMolecule | Peptide from protein | QVHPQKVTK | 9 | null | 186 | 194 | 9606 | P07288.2 | null | Exact Epitope | null | MhcBinding | 17307902 | 185 | Table I | Positive | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 4 |
315269.xml | 315269 | 2025-11-06-08:00 | 9743387 | 1,998 | Generation of human cytolytic T lymphocyte lines directed against prostate-specific antigen (PSA) employing a PSA oligoepitope peptide. | Journal of immunology (Baltimore, Md. : 1950) | P Correale; K Walmsley; S Zaremba; M Zhu; J Schlom; K Y Tsang | 1859267 | PSA-9 | FragmentOfANaturalSequenceMolecule | Peptide from protein | QVHPQKVTK | 9 | null | 186 | 194 | 9606 | P07288.2 | null | Exact Epitope | null | MhcBinding | 17307906 | 185 | Table I | Negative | false | null | null | null | null | null | null | null | null | null | null | null | null | null | 4 |
315270.xml | 315270 | 2026-01-22-08:00 | 9743519 | 1,998 | Translation of a retained intron in tyrosinase-related protein (TRP) 2 mRNA generates a new cytotoxic T lymphocyte (CTL)-defined and shared human melanoma antigen not expressed in normal cells of the melanocytic lineage. | The Journal of experimental medicine | R Lupetti; P Pisarra; A Verrecchia; C Farina; G Nicolini; A Anichini; C Bordignon; M Sensi; G Parmiani; C Traversari | 2151211 | TRP-2-INT2 222-231 | FragmentOfANaturalSequenceMolecule | Peptide from protein | EVISCKLIKR | 10 | null | 222 | 231 | 9606 | O75767 | null | Exact Epitope | null | TCell | 25375874 | 649 | Figure 2, 4 | Positive | true | null | 9606 | null | null | DOID:1909 | 230 | null | T cell CD8+ | blood | Cell Line / Clone | Exact match to reference information | Representative selection | null | 6 |
315270.xml | 315270 | 2026-01-22-08:00 | 9743519 | 1,998 | Translation of a retained intron in tyrosinase-related protein (TRP) 2 mRNA generates a new cytotoxic T lymphocyte (CTL)-defined and shared human melanoma antigen not expressed in normal cells of the melanocytic lineage. | The Journal of experimental medicine | R Lupetti; P Pisarra; A Verrecchia; C Farina; G Nicolini; A Anichini; C Bordignon; M Sensi; G Parmiani; C Traversari | 2151211 | TRP-2-INT2 222-231 | FragmentOfANaturalSequenceMolecule | Peptide from protein | EVISCKLIKR | 10 | null | 222 | 231 | 9606 | O75767 | null | Exact Epitope | null | TCell | 25375875 | 67 | Figure 5, 6 | Positive | true | null | 9606 | null | null | DOID:1909 | 230 | null | T cell CD8+ | blood | Cell Line / Clone | Exact match to reference information | Representative selection | null | 6 |
315270.xml | 315270 | 2026-01-22-08:00 | 9743519 | 1,998 | Translation of a retained intron in tyrosinase-related protein (TRP) 2 mRNA generates a new cytotoxic T lymphocyte (CTL)-defined and shared human melanoma antigen not expressed in normal cells of the melanocytic lineage. | The Journal of experimental medicine | R Lupetti; P Pisarra; A Verrecchia; C Farina; G Nicolini; A Anichini; C Bordignon; M Sensi; G Parmiani; C Traversari | 2151211 | TRP-2-INT2 222-231 | FragmentOfANaturalSequenceMolecule | Peptide from protein | EVISCKLIKR | 10 | null | 222 | 231 | 9606 | O75767 | null | Exact Epitope | null | TCell | 25375876 | 67 | Figure 6 | Positive | true | null | 9606 | null | null | DOID:1909 | 226 | null | T cell CD8+ | blood | Cell Line / Clone | Exact match to reference information | Representative selection | null | 6 |
315270.xml | 315270 | 2026-01-22-08:00 | 9743519 | 1,998 | Translation of a retained intron in tyrosinase-related protein (TRP) 2 mRNA generates a new cytotoxic T lymphocyte (CTL)-defined and shared human melanoma antigen not expressed in normal cells of the melanocytic lineage. | The Journal of experimental medicine | R Lupetti; P Pisarra; A Verrecchia; C Farina; G Nicolini; A Anichini; C Bordignon; M Sensi; G Parmiani; C Traversari | 2151211 | TRP-2-INT2 222-231 | FragmentOfANaturalSequenceMolecule | Peptide from protein | EVISCKLIKR | 10 | null | 222 | 231 | 9606 | O75767 | null | Exact Epitope | null | TCell | 25375877 | 649 | Table 2 | Positive | true | null | 9606 | null | null | DOID:1909 | 230 | null | T cell CD8+ | blood | Cell Line / Clone | Representative selection | Representative selection | null | 6 |
315270.xml | 315270 | 2026-01-22-08:00 | 9743519 | 1,998 | Translation of a retained intron in tyrosinase-related protein (TRP) 2 mRNA generates a new cytotoxic T lymphocyte (CTL)-defined and shared human melanoma antigen not expressed in normal cells of the melanocytic lineage. | The Journal of experimental medicine | R Lupetti; P Pisarra; A Verrecchia; C Farina; G Nicolini; A Anichini; C Bordignon; M Sensi; G Parmiani; C Traversari | 2151211 | TRP-2-INT2 222-231 | FragmentOfANaturalSequenceMolecule | Peptide from protein | EVISCKLIKR | 10 | null | 222 | 231 | 9606 | O75767 | null | Exact Epitope | null | TCell | 25375873 | 649 | Figure 1, Table 2 | Positive | true | null | 9606 | null | null | DOID:1909 | 230 | null | T cell CD8+ | blood | Cell Line / Clone | Representative selection | Representative selection | null | 6 |
315272.xml | 315272 | 2023-08-18-07:00 | 9747889 | 1,998 | Molecular basis of IgE-recognition of Lol p 5, a major allergen of rye-grass pollen. | Molecular immunology | C Suphioglu; B Blaher; J M Rolland; J McCluskey; G Schäppi; J Kenrick; M B Singh; R B Knox | 315 | Lol p 5 peptide 7 | FragmentOfANaturalSequenceMolecule | Peptide from protein | AANAPPADKFKI | 12 | null | 74 | 85 | 4522 | Q9XF24.1 | null | Exact Epitope | Not determined | BCell | 316511 | 37 | Tables 1, 2 and Figure 1 | Positive | true | null | 9606 | null | null | DOID:0060497 | null | null | null | null | null | Exact match to reference information | Not determined | null | 1 |
315272.xml | 315272 | 2023-08-18-07:00 | 9747889 | 1,998 | Molecular basis of IgE-recognition of Lol p 5, a major allergen of rye-grass pollen. | Molecular immunology | C Suphioglu; B Blaher; J M Rolland; J McCluskey; G Schäppi; J Kenrick; M B Singh; R B Knox | 25279 | Lol p 5 peptide 16 | FragmentOfANaturalSequenceMolecule | Peptide from protein | IAGALEVHAVKPA | 13 | null | 146 | 158 | 4522 | Q9XF24.1 | null | Epitope containing region/antigenic site | Not determined | BCell | 316512 | 37 | Table 1 and Figure 1 | Positive | true | null | 9606 | null | null | DOID:0060497 | null | null | null | null | null | Exact match to reference information | Not determined | null | 2 |
315272.xml | 315272 | 2023-08-18-07:00 | 9747889 | 1,998 | Molecular basis of IgE-recognition of Lol p 5, a major allergen of rye-grass pollen. | Molecular immunology | C Suphioglu; B Blaher; J M Rolland; J McCluskey; G Schäppi; J Kenrick; M B Singh; R B Knox | 19355 | Lol p 5 peptide 19 | FragmentOfANaturalSequenceMolecule | Peptide from protein | GELQIVDKIDAA | 12 | null | 170 | 181 | 4522 | Q9XF24.1 | null | Exact Epitope | Not determined | BCell | 316513 | 37 | Table 1 and Figure 1 | Positive | true | null | 9606 | null | null | DOID:0060497 | null | null | null | null | null | Exact match to reference information | Not determined | null | 7 |
315272.xml | 315272 | 2023-08-18-07:00 | 9747889 | 1,998 | Molecular basis of IgE-recognition of Lol p 5, a major allergen of rye-grass pollen. | Molecular immunology | C Suphioglu; B Blaher; J M Rolland; J McCluskey; G Schäppi; J Kenrick; M B Singh; R B Knox | 4864 | Lol p 5 peptide 21 | FragmentOfANaturalSequenceMolecule | Peptide from protein | ATAANAAPTNDK | 12 | null | 186 | 197 | 4522 | Q9XF24.1 | null | Exact Epitope | Not determined | BCell | 316514 | 37 | Table 1 and Figure 1 | Positive | true | null | 9606 | null | null | DOID:0060497 | null | null | null | null | null | Exact match to reference information | Not determined | null | 9 |
315272.xml | 315272 | 2023-08-18-07:00 | 9747889 | 1,998 | Molecular basis of IgE-recognition of Lol p 5, a major allergen of rye-grass pollen. | Molecular immunology | C Suphioglu; B Blaher; J M Rolland; J McCluskey; G Schäppi; J Kenrick; M B Singh; R B Knox | 14109 | Lol p 5 peptide 23 | FragmentOfANaturalSequenceMolecule | Peptide from protein | ESAFNKALNECT | 12 | null | 202 | 213 | 4522 | Q9XF24.1 | null | Exact Epitope | Not determined | BCell | 316515 | 37 | Table 1 and Figure 1 | Positive | true | null | 9606 | null | null | DOID:0060497 | null | null | null | null | null | Exact match to reference information | Not determined | null | 8 |
315272.xml | 315272 | 2023-08-18-07:00 | 9747889 | 1,998 | Molecular basis of IgE-recognition of Lol p 5, a major allergen of rye-grass pollen. | Molecular immunology | C Suphioglu; B Blaher; J M Rolland; J McCluskey; G Schäppi; J Kenrick; M B Singh; R B Knox | 3201 | Lol p 5 peptide 30 | FragmentOfANaturalSequenceMolecule | Peptide from protein | AMTQAQKAGKPA | 12 | null | 259 | 270 | 4522 | Q9XF24.1 | null | Exact Epitope | Not determined | BCell | 316516 | 37 | Table 1 and Figure 1 | Positive | true | null | 9606 | null | null | DOID:0060497 | null | null | null | null | null | Exact match to reference information | Not determined | null | 3 |
315272.xml | 315272 | 2023-08-18-07:00 | 9747889 | 1,998 | Molecular basis of IgE-recognition of Lol p 5, a major allergen of rye-grass pollen. | Molecular immunology | C Suphioglu; B Blaher; J M Rolland; J McCluskey; G Schäppi; J Kenrick; M B Singh; R B Knox | 18529 | Lol p 5 peptide 34 | FragmentOfANaturalSequenceMolecule | Peptide from protein | GAATAAAGGYKA | 12 | null | 290 | 301 | 4522 | Q9XF24.1 | null | Exact Epitope | Not determined | BCell | 1476003 | 37 | Figure 4 | Negative | false | null | 9606 | null | null | DOID:0060497 | null | null | null | null | null | Not determined | Not determined | null | 6 |
315272.xml | 315272 | 2023-08-18-07:00 | 9747889 | 1,998 | Molecular basis of IgE-recognition of Lol p 5, a major allergen of rye-grass pollen. | Molecular immunology | C Suphioglu; B Blaher; J M Rolland; J McCluskey; G Schäppi; J Kenrick; M B Singh; R B Knox | 18529 | Lol p 5 peptide 34 | FragmentOfANaturalSequenceMolecule | Peptide from protein | GAATAAAGGYKA | 12 | null | 290 | 301 | 4522 | Q9XF24.1 | null | Exact Epitope | Not determined | BCell | 316517 | 34 | Tables 1, 3 and Figures 1-3 | Positive | true | null | 9606 | null | null | DOID:0060497 | null | null | null | null | null | Exact match to reference information | Not determined | null | 6 |
315272.xml | 315272 | 2023-08-18-07:00 | 9747889 | 1,998 | Molecular basis of IgE-recognition of Lol p 5, a major allergen of rye-grass pollen. | Molecular immunology | C Suphioglu; B Blaher; J M Rolland; J McCluskey; G Schäppi; J Kenrick; M B Singh; R B Knox | 18529 | Lol p 5 peptide 34 | FragmentOfANaturalSequenceMolecule | Peptide from protein | GAATAAAGGYKA | 12 | null | 290 | 301 | 4522 | Q9XF24.1 | null | Exact Epitope | Not determined | BCell | 1476009 | 37 | Figure 4 | Positive | true | null | 9606 | null | null | DOID:0060497 | null | null | null | null | null | Not determined | Not determined | null | 6 |
315272.xml | 315272 | 2023-08-18-07:00 | 9747889 | 1,998 | Molecular basis of IgE-recognition of Lol p 5, a major allergen of rye-grass pollen. | Molecular immunology | C Suphioglu; B Blaher; J M Rolland; J McCluskey; G Schäppi; J Kenrick; M B Singh; R B Knox | 18529 | Lol p 5 peptide 34 | FragmentOfANaturalSequenceMolecule | Peptide from protein | GAATAAAGGYKA | 12 | null | 290 | 301 | 4522 | Q9XF24.1 | null | Exact Epitope | Not determined | BCell | 1476008 | 37 | Figure 4 | Positive | true | null | 9606 | null | null | DOID:0060497 | null | null | null | null | null | Not determined | Not determined | null | 6 |
315272.xml | 315272 | 2023-08-18-07:00 | 9747889 | 1,998 | Molecular basis of IgE-recognition of Lol p 5, a major allergen of rye-grass pollen. | Molecular immunology | C Suphioglu; B Blaher; J M Rolland; J McCluskey; G Schäppi; J Kenrick; M B Singh; R B Knox | 18529 | Lol p 5 peptide 34 | FragmentOfANaturalSequenceMolecule | Peptide from protein | GAATAAAGGYKA | 12 | null | 290 | 301 | 4522 | Q9XF24.1 | null | Exact Epitope | Not determined | BCell | 1476017 | 37 | Figure 4 | Negative | false | null | 9606 | null | null | DOID:0060497 | null | null | null | null | null | Not determined | Not determined | null | 6 |
315272.xml | 315272 | 2023-08-18-07:00 | 9747889 | 1,998 | Molecular basis of IgE-recognition of Lol p 5, a major allergen of rye-grass pollen. | Molecular immunology | C Suphioglu; B Blaher; J M Rolland; J McCluskey; G Schäppi; J Kenrick; M B Singh; R B Knox | 18529 | Lol p 5 peptide 34 | FragmentOfANaturalSequenceMolecule | Peptide from protein | GAATAAAGGYKA | 12 | null | 290 | 301 | 4522 | Q9XF24.1 | null | Exact Epitope | Not determined | BCell | 1475992 | 37 | Figure 4 | Positive | true | null | 9606 | null | null | DOID:0060497 | null | null | null | null | null | Not determined | Not determined | null | 6 |
315272.xml | 315272 | 2023-08-18-07:00 | 9747889 | 1,998 | Molecular basis of IgE-recognition of Lol p 5, a major allergen of rye-grass pollen. | Molecular immunology | C Suphioglu; B Blaher; J M Rolland; J McCluskey; G Schäppi; J Kenrick; M B Singh; R B Knox | 18529 | Lol p 5 peptide 34 | FragmentOfANaturalSequenceMolecule | Peptide from protein | GAATAAAGGYKA | 12 | null | 290 | 301 | 4522 | Q9XF24.1 | null | Exact Epitope | Not determined | BCell | 1476018 | 37 | Figure 4 | Positive | true | null | 9606 | null | null | DOID:0060497 | null | null | null | null | null | Not determined | Not determined | null | 6 |
315272.xml | 315272 | 2023-08-18-07:00 | 9747889 | 1,998 | Molecular basis of IgE-recognition of Lol p 5, a major allergen of rye-grass pollen. | Molecular immunology | C Suphioglu; B Blaher; J M Rolland; J McCluskey; G Schäppi; J Kenrick; M B Singh; R B Knox | 18529 | Lol p 5 peptide 34 | FragmentOfANaturalSequenceMolecule | Peptide from protein | GAATAAAGGYKA | 12 | null | 290 | 301 | 4522 | Q9XF24.1 | null | Exact Epitope | Not determined | BCell | 1475817 | 34 | Figures 2-4 | Positive | true | null | 9606 | null | null | DOID:0060497 | null | null | null | null | null | Not determined | Not determined | null | 6 |
315272.xml | 315272 | 2023-08-18-07:00 | 9747889 | 1,998 | Molecular basis of IgE-recognition of Lol p 5, a major allergen of rye-grass pollen. | Molecular immunology | C Suphioglu; B Blaher; J M Rolland; J McCluskey; G Schäppi; J Kenrick; M B Singh; R B Knox | 18529 | Lol p 5 peptide 34 | FragmentOfANaturalSequenceMolecule | Peptide from protein | GAATAAAGGYKA | 12 | null | 290 | 301 | 4522 | Q9XF24.1 | null | Exact Epitope | Not determined | BCell | 1476016 | 37 | Figure 4 | Positive | true | null | 9606 | null | null | DOID:0060497 | null | null | null | null | null | Not determined | Not determined | null | 6 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.